Since obese PCOS patients are more likely to have higher degrees of insulin insensitivity, affecting only hypothalamic-gonadal axis (HPG) axis dysregulation may not address the ability for insulin pathways to contribute to PCOS pathogenesis. The gene discussed is INS; the disease is polycystic ovary syndrome.